SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS

The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure...

Full description

Saved in:
Bibliographic Details
Main Authors SANDNER, Peter, WEBSTER, Robert Alan, STELLFELD, Timo, BOULTADAKIS-ARAPINIS, Melissa, MATHAR, Ilka, COLLIN-KRÖPELIN, Marie-Pierre, HOFMEISTER, Lucas Hudson, DIETZ, Lisa, SCHMECK, Carsten, WUNDER, Frank, DIESKAU, Andre, CANDISH, Lisa, VAKALOPOULOS, Alexandros, ORTEGA HERNANDEZ, Nuria
Format Patent
LanguageEnglish
Published 28.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure with reduced and preserved ejection fraction (HFrEF, HFmrEF and HFpEF), hypertension (HTN), peripheral arterial diseases (PAD, PAOD), cardio-renal and kidney diseases, preferably chronic and diabetic kidney disease (CKD and DKD), cardiopulmonary and lung diseases, preferable pulmonary hypertension (PH), and other diseases, preferably neurodegenerative diseases and different forms of dementias, fibrotic diseases, systemic sclerosis (SSc), sickle cell disease (SCD), wound healing disorders such as diabetic foot ulcer (DFU).
Bibliography:Application Number: US202118256650